Cargando…
Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction
BACKGROUND: Insulin-like growth factor binding protein-7 (IGFBP-7) modulates the biological activities of insulin-like growth factor-1 (IGF-1). Previous studies demonstrated the prognostic value of IGFBP-7 and IGF-1 among patients with systolic heart failure (HF). This study aimed to evaluate the IG...
Autores principales: | Barroso, Michael Coll, Kramer, Frank, Greene, Stephen J., Scheyer, Daniel, Köhler, Till, Karoff, Martin, Seyfarth, Melchior, Gheorghiade, Mihai, Dinh, Wilfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073807/ https://www.ncbi.nlm.nih.gov/pubmed/27769173 http://dx.doi.org/10.1186/s12872-016-0376-2 |
Ejemplares similares
-
Endostatin a Potential Biomarker for Heart Failure with Preserved
Ejection Fraction
por: Barroso, Michael Coll, et al.
Publicado: (2017) -
High sensitive troponin T and heart fatty acid binding protein: Novel biomarker in heart failure with normal ejection fraction?: A cross-sectional study
por: Dinh, Wilfried, et al.
Publicado: (2011) -
Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017) -
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
por: Greene, Stephen J., et al.
Publicado: (2013) -
Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)